Synergistic post-transcriptional regulation of the cystic fibrosis transmembrane conductance regulator (CFTR) by miR-101 and miR-494 specific binding

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Megiorni, Francesca ^a   Cialfi, Samantha ^a   Dominici, Carlo ^a   Quattrucci, Serena ^a   Pizzuti, Antonio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 101; MICRORNA 494; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; MIRN101 MICRORNA, HUMAN; MIRN494 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; EMBRYO; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PROCESSING; REGULATOR GENE; TRANSMEMBRANE CONDUCTANCE REGULATOR GENE; ANIMAL; BIOLOGY; CELL STRAIN HEK293; ENZYME SPECIFICITY; GENE SILENCING; GENETICS; METABOLISM; MOUSE; RNA PROCESSING;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; COMPUTATIONAL BIOLOGY; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENE SILENCING; HEK293 CELLS; HUMANS; MICE; MICRORNAS; RNA PROCESSING, POST-TRANSCRIPTIONAL; SUBSTRATE SPECIFICITY;

EID: 80054777791     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026601     Document Type: Article

References (28)

1. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066-1073.
2. Collaco JM, Cutting GR, (2008) Update on gene modifiers in cystic fibrosis. Curr Opin Pulm Med 14: 559-66.
3. Cutting GR, (2010) Modifier genes in Mendelian disorders: the example of cystic fibrosis. Ann N Y Acad Sci 1214: 57-69.
4. Xu W, Hui C, Yu SS, Jing C, Chan HC, (2011) MicroRNAs and cystic fibrosis-an epigenetic perspective. Cell Biol Int 35: 463-466.
5. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R, (2006) Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20: 515-524.
6. Yoda M, Kawamata T, Paroo Z, Ye X, Iwasaki S, (2010) ATP-dependent human RISC assembly pathways Nat Struct Mol Biol 17: 17-23.
7. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
8. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009) Most Mammalian mRNAs Are Conserved Targets of MicroRNAs. Genome Res 19: 92-105.
9. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ, (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: 140-144.
10. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: 154-158.
11. Berezikov E, Guryev V, van deBelt J, (2005) Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120: 21-24.
12. Bandiera S, Hatem E, Lyonnet S, Henrion-Caude A, (2010) microRNAs in diseases: from candidate to modifier genes. Clin Genet 77: 306-313.
13. Oglesby IK, Bray IM, Chotirmall SH, Stallings RL, O'Neill SJ, et al. (2010) miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression. J Immunol 184: 1702-1709.
14. Bazett M, Paun A, Haston CK, (2011) MicroRNA profiling of cystic fibrosis intestinal disease in mice. Mol Genet Metab 103: 38-43.
15. Bhattacharyya S, Balakathiresan NS, Dalgard C, Gutti U, Armistead D, et al. (2011) Elevated miR-155 Promotes Inflammation in Cystic Fibrosis by Driving Hyperexpression of Interleukin-8. J Biol Chem 286: 11604-11615.
16. Xiao F, Zuo Z, Cai G, Kang S, Gao X, et al. (2009) miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res 37: 105-110.
17. Betel D, Wilson M, Gabow A, Marks DS, Sander C, (2008) microRNA target predictions: The microRNA.org resource: targets and expression. Nucleic Acids Res 36: 149-153.
18. Gillen AE, Gosalia N, Leir SH, Harris A, (2011) MicroRNA regulation of expression of the cystic fibrosis transmembrane conductance regulator gene. Biochem J 438: 25-32.
19. Spence J, (2009) Pathway prediction by bioinformatic analysis of the untranslated regions of the CFTR mRNA. Genomics 94: 39-47.
20. Williams AE, Larner-Svensson H, Perry MM, Campbell GA, Herrick SE, et al. (2009) MicroRNA Expression Profiling in Mild Asthmatic Human Airways and Effect of Corticosteroid Therapy. PLoS One 4: e5889.
21. Jardim MJ, Fry RC, Jaspers I, Dailey L, Diaz-Sanchez D, (2009) Disruption of microRNA expression in human airway cells by diesel exhaust particles is linked to tumorigenesis-associated pathways. Environ Health Perspect 117: 1745-1751.
22. Duan H, Jiang Y, Zhang H, Wu Y, (2010) MiR-320 and miR-494 affect cell cycles of primary murine bronchial epithelial cells exposed to benzo[a]pyrene. Toxicol In Vitro 24: 928-935.
23. Zhu QY, Liu Q, Chen JX, Lan K, Ge BX, (2010) MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages. J Immunol 15: 7435-7442.
24. Vilardo E, Barbato C, Ciotti M, Cogoni C, Ruberti F, (2010) MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons. J Biol Chem 285: 18344-18351.
25. Goldstein AB, Goldstein LS, Perl MK, Haug MT, Arroliga AC, et al. (2000) Cystic fibrosis patients with and without central nervous system complications following lung transplantation. Pediatr Pulmonol 30: 203-206.
26. Keene JD, (2007) RNA regulons: coordination of post-transcriptional events. Nat Rev Genet 8: 533-543.
27. Cacchiarelli D, Legnini I, Martone J, Cazzella V, D'Amico A, et al. (2011) miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol Med 3: 258-265.
28. Cacchiarelli D, Incitti T, Martone J, Cesana M, Cazzella V, et al. (2011) miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy. EMBO Rep 12: 136-141.